Home › Funds › Tyro Capital Management LLC › NGNE

Tyro Capital Management LLC position in NGNE

NEUROGENE INC · Health Care

Tyro Capital Management LLC reported holding 304,401 shares of NGNE (NEUROGENE INC) in its Q3 2026 13F filing — a position valued at US$8.5M, representing 1.50% of its reported portfolio and ranking #20 among its reported holdings. Tyro Capital Management LLC first reported this position in Q3 2026.

Latest position (Q3 2026)304.40K sh
Reported value held$8.47M
Portfolio Weight1.50%
First reportedQ3 2026
Last changeNew
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Tyro Capital Management LLC's NGNE position evolved

Tyro Capital Management LLC first disclosed a stake in NGNE in Q3 2026 at 304,401 shares (US$8.5M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 304.40K $8.47M New

About NGNE and 13F data

NGNE (NEUROGENE INC) is a Health Care company. 38 other funds we track also report a position in NGNE — the largest reported positions include Samsara BioCapital, LLC (US$54.0M), Casdin Capital (US$48.6M), Redmile Group, LLC (US$44.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NGNE

All NGNE fund holders →

FAQ

How long has Tyro Capital Management LLC held NGNE?

Tyro Capital Management LLC has disclosed NGNE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Tyro Capital Management LLC's current position in NGNE?

As of Q3 2026, Tyro Capital Management LLC holds 304.40K shares of NGNE (NEUROGENE INC), valued at $8.47M, representing 1.50% of its reported portfolio and ranking #20.

Has Tyro Capital Management LLC been buying or selling NGNE?

In the latest 13F filing (Q3 2026), Tyro Capital Management LLC newly opened its position in NGNE.

Which other funds hold NGNE?

Other major institutional holders of NGNE include Samsara BioCapital, LLC, Casdin Capital, Redmile Group, LLC, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.